Physician profile
Gary Cortese
NPI 1497759336
$1,344.14
in general payments reported to CMS, 2019-2025
9 companies · $451 in 2025
The $451 reported for 2025 was more than what a typical Primary Podiatric Medicine provider received nationally (typical 2025 total: $232).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.59 · 2020: $34.77 · 2021: $209 · 2022: $305 · 2023: $88.00 · 2024: $245 · 2025: $451.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $448 · Education: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $447.87 |
| Education | $336.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $380.59 | 2024-2025 | Dr Comfort |
| Organogenesis INC. | $286.79 | 2023-2025 | Novachor, Puraply, Cygnus Dual |
| Horizon Therapeutics Plc | $285.30 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $228.78 | 2022-2024 | Nuzyra |
| Rikco International, LLC | $93.00 | 2021 | |
| Averitas Pharma INC. | $26.02 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $16.43 | 2025 | |
| Smith+Nephew, INC. | $15.64 | 2024 | Collagenase Santyl |
| Merck Sharp & Dohme LLC | $11.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Cortese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.